Risk Factors for the Prediction of Treatment Failure in Gestational Trophoblastic Tumors Treated with EMA/CO Regimen
- 30 November 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 71 (2) , 247-253
- https://doi.org/10.1006/gyno.1998.5161
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Management of high-risk gestational trophoblastic disease - The Memorial Hospital experienceInternational Journal of Gynecologic Cancer, 1997
- An evaluation of the prognostic factors in metastatic gestational trophoblastic diseaseInternational Journal of Gynecologic Cancer, 1994
- Prognostic factors in gestational trophoblastic tumors: A proposed new scoring system based on multivariate analysisAmerican Journal of Obstetrics and Gynecology, 1991
- Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumorsGynecologic Oncology, 1984
- Intensive inpatient therapy and survival in gestational trophoblastic diseaseGynecologic Oncology, 1983
- Treatment of metastatic gestational trophoblastic neoplasmsAmerican Journal of Obstetrics and Gynecology, 1980
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976
- Treatment of metastatic trophoblastic disease: Good and poor prognosisAmerican Journal of Obstetrics and Gynecology, 1973
- Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in womenAmerican Journal of Obstetrics and Gynecology, 1965
- Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in womenAmerican Journal of Obstetrics and Gynecology, 1961